Literature DB >> 18071246

Studies on the later stage of the biosynthesis of pleuromutilin.

Tae Tsukagoshi1, Tetsuo Tokiwano, Hideaki Oikawa.   

Abstract

Mutilin (4) and deoxy analogues 2 and 3 are biosynthetic precursors of pleuromutilin (1) in the later stage of biosynthesis. Precursors 2 and 3 are required for studies on the oxygenation steps in biosynthesis, and were synthesized from readily available 1 via 4 by deoxygenation of the hydroxy groups. Feeding experiments with the (2)H-labeled precursors confirmed their microbial conversion into 1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071246     DOI: 10.1271/bbb.70547

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Premutilin Synthase: Ring Rearrangement by a Class II Diterpene Cyclase.

Authors:  Meimei Xu; Meirong Jia; Young J Hong; Xihou Yin; Dean J Tantillo; Philip J Proteau; Reuben J Peters
Journal:  Org Lett       Date:  2018-02-01       Impact factor: 6.005

2.  The good, the bad and the tasty: The many roles of mushrooms.

Authors:  K M J de Mattos-Shipley; K L Ford; F Alberti; A M Banks; A M Bailey; G D Foster
Journal:  Stud Mycol       Date:  2016-11-11       Impact factor: 16.097

3.  Heterologous expression reveals the biosynthesis of the antibiotic pleuromutilin and generates bioactive semi-synthetic derivatives.

Authors:  Fabrizio Alberti; Khairunisa Khairudin; Edith Rodriguez Venegas; Jonathan A Davies; Patrick M Hayes; Christine L Willis; Andy M Bailey; Gary D Foster
Journal:  Nat Commun       Date:  2017-11-28       Impact factor: 14.919

4.  Identification and manipulation of the pleuromutilin gene cluster from Clitopilus passeckerianus for increased rapid antibiotic production.

Authors:  Andy M Bailey; Fabrizio Alberti; Sreedhar Kilaru; Catherine M Collins; Kate de Mattos-Shipley; Amanda J Hartley; Patrick Hayes; Alison Griffin; Colin M Lazarus; Russell J Cox; Christine L Willis; Karen O'Dwyer; David W Spence; Gary D Foster
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.